Literature DB >> 15557551

Tolerability of antiseizure medications: implications for health outcomes.

Frank Gilliam1, Jewell Carter, Victoria Vahle.   

Abstract

Epilepsy is a disorder of abnormal excitability and synchronicity of aggregates of neurons that lead to paroxysmal behavioral or perceptual change. Most antiepileptic drugs (AEDs) decrease membrane excitability or increase postsynaptic inhibition, and may alter synchronization of neuronal networks. The attributes of an AED that reduce the tendency toward seizures may cause disruption of normal cerebral processes. Previous clinical studies suggest wide inter-individual variability of the effects of such AEDs. The options for antiepileptic treatment have dramatically expanded in the past decade and now allow tailoring of intervention for optimal management of individual patients. Current strategies to improve epilepsy care should include systematic monitoring to identify adverse effects of AEDs, and future approaches may involve creative applications of neuroimaging and genetic technologies to match patient characteristics to AED attributes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557551     DOI: 10.1212/wnl.63.10_suppl_4.s9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the rat.

Authors:  Clifford L Eastman; Derek R Verley; Jason S Fender; Nancy R Temkin; Raimondo D'Ambrosio
Journal:  Exp Neurol       Date:  2010-04-24       Impact factor: 5.330

2.  Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.

Authors:  Clifford L Eastman; Jason S Fender; Nancy R Temkin; Raimondo D'Ambrosio
Journal:  Exp Neurol       Date:  2014-12-16       Impact factor: 5.330

3.  Antiepileptic use for epilepsy and nonepilepsy disorders: A population-based study (1998-2013).

Authors:  Christine Leong; Muhammad M Mamdani; Tara Gomes; David N Juurlink; Erin M Macdonald; Marina Yogendran
Journal:  Neurology       Date:  2016-02-05       Impact factor: 9.910

4.  Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.

Authors:  Toufic A Fakhoury; J Mitchell Miller; Anne E Hammer; Alain Vuong
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  [The use of lamotrigine in female patients].

Authors:  B Schmitz; L Bergmann
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

6.  Adverse antiepileptic drug effects in new-onset seizures: a case-control study.

Authors:  P Perucca; A Jacoby; A G Marson; G A Baker; S Lane; E K T Benn; D J Thurman; W A Hauser; F G Gilliam; D C Hesdorffer
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

7.  Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study).

Authors:  Martha Losada-Camacho; Mario F Guerrero-Pabon; Pilar Garcia-Delgado; Fernando Martínez-Martinez
Journal:  Health Qual Life Outcomes       Date:  2014-10-31       Impact factor: 3.186

Review 8.  Epilepsy in the Elderly: Treatment and Consideration of Comorbid Diseases.

Authors:  Sang Kun Lee
Journal:  J Epilepsy Res       Date:  2019-06-30

9.  Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy.

Authors:  Vivek Kumar Garg; Manoj Kumar Goyal; Madhu Khullar; Biman Saikia; Bikash Medhi; Ajay Prakash; Nandita Prabhat; Naresh Tandyala; Karthik Vinay Mahesh; Parampreet S Kharbanda; Sudesh Prabhakar; Manish Modi; Vivek Lal; Ritu Shree; Julie Sachdeva
Journal:  Indian J Pharmacol       Date:  2020 Sep-Oct       Impact factor: 1.200

10.  Reappraisal of the Medical Research Council Antiepileptic Drug Withdrawal Study: Contamination-adjusted and dose-response re-analysis.

Authors:  Samuel W Terman; Chang Wang; Lu Wang; Kees P J Braun; Willem M Otte; Geertruida Slinger; Wesley T Kerr; Morten I Lossius; Laura Bonnett; James F Burke; Anthony Marson
Journal:  Epilepsia       Date:  2022-05-18       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.